Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains
The increasing multidrug resistance in Helicobacter pylori , also correlated to its biofilm‐forming ability, underlines the need to search novel strategies to improve the eradication rate. Natural compounds are proposed as antibiotic-resistant-breakers capable to restore the efficacy of conventional...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2019-03, Vol.9 (1), p.4646, Article 4646 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The increasing multidrug resistance in
Helicobacter pylori
, also correlated to its biofilm‐forming ability, underlines the need to search novel strategies to improve the eradication rate. Natural compounds are proposed as antibiotic-resistant-breakers capable to restore the efficacy of conventional drugs. Aim of this work was to evaluate the capability of
Pistacia vera
L. oleoresin (ORS) to synergize with levofloxacin (LVX) against resistant
H
.
pylori
strains. The antimicrobial activity of
P
.
vera
L. ORS and LVX and their combinations was determined by MIC/MBC (in neutral and acidic environments) and checkerboard tests. The anti-biofilm effect was determined by biomass quantification.
In vivo Galleria mellonella
model was used to confirm
in vitro
data.
Pistacia vera
L. ORS and LVX MICs ranged respectively from 780 to 3120 mg/l and from 0.12 to 2.00 mg/l, at pH 7.0 and 5.5. MBCs were similar to MICs.
Pistacia vera
L. ORS was able to synergize with LVX, restoring its effectiveness in LVX resistant strains.
Pistacia vera
L. ORS, LVX and their synergistic combinations displayed significant biofilm reduction.
Pistacia vera
L. ORS and LVX, showed protective effect against
H
.
pylori
infection on
G
.
mellonella
(62% and 63% of survival, respectively).
Pistacia vera
L. ORS can be considered a promising potentiator to restore the effectiveness of LVX tackling the
H
.
pylori
antibiotic resistance phenomenon. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-019-40991-y |